PHARMARESEARCH BIO Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2014	FY 2014
Period Ending	Dec '14 Dec 31, 2014	Mar '14 Mar 31, 2014
Cash & Equivalents	428.99	810.8
Cash & Short-Term Investments	428.99	810.8
Cash Growth	-47.09%	-
Accounts Receivable	-	55
Other Receivables	0.03	1.65
Receivables	0.03	56.65
Prepaid Expenses	0.11	0.74
Other Current Assets	2.51	-
Total Current Assets	431.64	868.18
Property, Plant & Equipment	30.85	4.99
Other Long-Term Assets	53	31.37
Total Assets	515.49	904.54
Accrued Expenses	20.05	10.69
Short-Term Debt	16.4	54.4
Other Current Liabilities	10.05	4.01
Total Current Liabilities	46.49	69.1
Long-Term Debt	1,027	949.62
Other Long-Term Liabilities	-0	-
Total Liabilities	1,360	1,086
Common Stock	200	200
Additional Paid-In Capital	82.51	82.51
Retained Earnings	-1,121	-458.82
Comprehensive Income & Other	-5.23	-5.23
Shareholders' Equity	-844.19	-181.55
Total Liabilities & Equity	515.49	904.54
Total Debt	1,043	1,004
Net Cash (Debt)	-614.18	-193.22
Net Cash Per Share	-15354.38	-4830.40
Filing Date Shares Outstanding	0.04	0.04
Total Common Shares Outstanding	0.04	0.04
Working Capital	385.15	799.08
Book Value Per Share	-21104.72	-4538.56
Tangible Book Value	-844.19	-181.55
Tangible Book Value Per Share	-21104.72	-4538.56
Machinery	37.42	11.23

Source: S&P Global Market Intelligence. Standard template. Financial Sources.